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ABSTRACT 
BACKGROUND: Although laparoscopic adjustable gastric banding (LAGB) and 
laparoscopic sleeve gastrectomy (LSG) are coexisting first-choice restrictive procedures for 
bariatric surgery candidates, it is possible, given their different modes of action, that these 
procedures have different effects on quality of life (QOL). We hypothesized that improvement 
of QOL and comfort with food could be better with LSG compared to LAGB. 
METHODS: This cohort study included 131 obese patients who had either LAGB (n=102) or 
LSG (n=29). Patients were assessed during preoperative and at 6- and 12-month postoperative 
visits. Five QOL dimensions were assessed using the ‘Quality Of Life, Obesity and Dietetics’ 
rating scale: physical impact, psycho-social impact, impact on sex life, comfort with food, and 
diet experience. We compared QOL evolution between LAGB and LSG using linear mixed 
models adjusted for gender and body mass index at each visit. 
RESULTS: Excess weight loss was 28.4 ± 14.7% and 34.8 ± 18.4% for LAGB, and 35.7 ± 
14.3% and 43.8 ± 17.8% for LSG, at 6 and 12 months postoperatively, respectively. Both 
LAGB and LSG provided significant improvement in the physical, psycho-social, sexual, and 
diet experience dimensions of QOL. LSG was associated with better improvement than 
LAGB in short term (6-month) comfort with food. 
CONCLUSIONS: Our results add further evidence to the benefit of LSG and LAGB in 
obesity management. Within the first year of follow-up, there is no lasting difference in the 
comfort with food dimension between LSG and LABG.  
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INTRODUCTION 
Obesity is associated with decreased quality of life (QOL) [1]. Generic health-related QOL is 
lower in bariatric surgery candidates when compared to non-surgical obese patients, even 
after adjustment for body weight [2]. In obesity management, bariatric surgery is currently 
considered to efficiently produce long-term weight loss, improve comorbidities, and improve 
QOL [3]. Several studies have shown that improvement in QOL occurs as soon as three 
months after bariatric surgery. QOL then reaches a plateau after one to two years [4-6] and, in 
some cases, has been shown to match the data from a non-obese population [7]. With 
improvements in surgical techniques, QOL should be considered, in addition to weight loss, 
improvement in co-morbidities and postoperative risk, as a major outcome measure to guide 
the choice of surgical procedure.  
With lower operative and nutritional risks compared to mixed and malabsorptive 
procedures, there is currently much interest in restrictive procedures. Laparoscopic adjustable 
gastric banding (LAGB), a procedure that has been in clinical use for 15 years [8], is gaining 
popularity in the United States [9], and laparoscopic sleeve gastrectomy (LSG) was recently 
proposed as a standalone bariatric approach [10].  
Improvement of QOL is well documented following LAGB [11-16]. One and two 
years following LAGB, significant improvement in physical [11, 15, 16], psychosocial [11, 
14-16], and sexual functioning [13] are documented for both obesity-specific and generic 
tools, such as the Moorehead–Ardelt Quality of Life Questionnaire and the 36-item Short 
Form Health Survey (SF-36), respectively. Although data for LSG are more limited, 
improvement of obesity-specific QOL following LSG has been also demonstrated [17-19]. 
Comparison of the evolution of QOL, food tolerance, and quality of eating with LAGB and 
LSG were studied in a single study by Schweiger et al. [20]. In this study, LAGB was 
associated with significantly lower scores in these dimensions when compared with LSG, 
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Roux-en-Y gastric bypass, and biliopancreatic diversion with a duodenal switch. However, 
this study did not provide any preoperative QOL data [20].  
Although LAGB and LSG are coexisting first-choice restrictive bariatric procedures, it 
is possible that these procedures may have different effects on QOL. Indeed, low physical and 
psychological band tolerance has been reported [21] and recent data show that levels of 
plasma ghrelin, a hormone that stimulates hunger, are down-regulated with LSG but are up-
regulated with LAGB [22]. Therefore, we hypothesized that improvement in the ‘comfort 
with food’ dimension of QOL could be better with LSG compared to LAGB.  
The aim of this study was to compare the evolution of QOL, especially ‘comfort with 
food’, in patients following LAGB and LSG. 
 
METHODS 
Participants 
This cohort study was conducted in the Nutrition Department of the University Hospital of 
Tours, France. We enrolled consecutive obese patients who had undergone restrictive bariatric 
surgery (either LAGB or LSG) between November 1999 and July 2009, with patients having 
a follow-up period of at least one year. 
 
Measures 
We assessed the patients preoperatively, and at 6 and 12 months postoperatively. At the 
preoperative visit, we collected data on demographics (age, gender, socio-professional 
category, marital status), previous maximal body-mass index (BMI), current BMI, 
preoperative obesity comorbidities, history of previous bariatric surgery, waist circumference, 
hip circumference, medications, and QOL. At 6 and 12 months, we recorded weight, waist 
circumference, hip circumference, incidence of surgical reoperations, postoperative gastric 
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fistula rate, use of medications, and QOL. The per cent excess weight loss was calculated at 6 
and 12 months as follows: weight loss * 100 / (preoperative weight – weight if BMI was 25 
kg/m
2
). 
The main outcome variable was QOL, assessed with the ‘Quality Of Life, Obesity and 
Dietetics’ (QOLOD) rating scale [23]. The QOLOD is a French tool derived from the ‘Impact 
of Weight on Quality Of Life Questionnaire’, which was the first instrument specifically 
designed to assess QOL in obesity [24, 25]. The QOLOD is a 36-item scale, each item being 
rated on a 5-point scale. This scale includes 5 subscales: ‘physical impact’ (11 items), 
‘psycho-social impact’ (11 items), ‘impact on sex life’ (4 items), ‘comfort with food’ (5 
items), and ‘diet experience’ (5 items). Ziegler et al. verified the construction validity and 
internal reliability of the questionnaire for each of the 5 dimensions, as well as its concurrent 
validity in relation to the 12-item Short Form Health Survey (SF-12). Reproducibility was 
satisfactory with an intraclass correlation coefficient greater than 0.8 [23]. 
 
Statistical analyses  
We compared both groups’ characteristics using Wilcoxon and chi-squared tests. We used 
Fisher’s exact test when expected frequencies were too small. We compared QOL evolution 
between LAGB and LSG groups using linear mixed models. These models take into account 
intra-subject correlations due to longitudinal design and time-dependent covariates. Linear 
mixed models use all the available data, regardless of any missing data. Our models were 
adjusted according to gender and BMI (with the latter being a time-dependent covariates). 
The models were fitted with interaction terms between the type of surgery and the follow-up 
time. When the interaction term was not significant, the models were re-estimated without any 
interaction terms. Statistical analyses were performed with SAS Version 9.1 software for 
Windows (SAS Institute, Inc., Cary, NC, USA) and R 2.7.2 [26].  
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RESULTS 
Participants 
Figure 1 presents a study flow chart of the three questionnaire sessions. A total of 175 obese 
patients had either LAGB or LSG over the study period. Of these, 131 patients participated in 
the complete planned follow-up. Out of the 131 patients, 103 returned completed QOL 
questionnaires at the preoperative and at 6- and 12-month postoperative visits. Our analyses 
are based on 131 patients. 
 
Descriptive data 
Table 1 presents the patients’ demographics. The two groups did not significantly differ 
regarding age, gender, socio-professional category, marital status, or preoperative obesity 
comorbidities. The LSG group had a significantly higher preoperative BMI, and a higher 
previous maximal BMI. 
 
Weight loss and postoperative evolution 
BMI was significantly decreased from baseline up to the 12-month visit in both the LAGB 
and LSG groups (p <0.0001). The per cent excess weight loss was significantly greater in the 
LSG group compared to the LAGB group at 6 months (p=0.02) and at 12 months (p=0.02) 
(Table 2).  
Surgical reintervention rate at 12 months was not different between the LSG and the 
LAGB groups (p=0.77). The LSG group had higher postoperative gastric fistula rates than the 
LAGB group (p=0.01) (Table 2). 
 
Quality of life 
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Improvement in each of the five QOL dimensions was not better in the group who had prior 
surgery when compared to the group who had no prior bariatric surgery. Table 2 shows the 
descriptive data for the QOLOD subscale scores at the preoperative and at 6- and 12-month 
postoperative visits. Table 3 shows the fixed effects of the independent variables (time, 
gender, type of surgery, and BMI) on QOL. Except for ‘comfort with food’, we observed a 
significant time effect. A significant difference between the LAGB and LSG groups was 
observed for ‘psycho-social impact’ with a mean difference of 4.27 points in favor of the LSG 
group on a 55-point scale. A time-surgery interaction was observed for the ‘comfort with 
food’ scale, with a greater improvement in the LSG group compared to the LAGB group at 
the 6-month visit, but no longer at the 12-month visit. 
 
DISCUSSION 
In this study, data from the QOLOD questionnaire confirms that both LAGB and LSG 
provide significant improvement in the physical, psycho-social, sexual, and diet experience 
dimensions of QOL. ‘Comfort with food’ evolution was significantly better in the LSG 
compared to the LAGB group at the 6-month visit, but no longer at the 12-month visit. 
 Sex ratio, mean age, and preoperative obesity comorbidity rates (except for sleep-
apnea syndrome) in our study population are comparable to that observed in Buchwald’s 
meta-analysis, which included a total 135,246 patients in 621 studies [27]. However, our 
population had higher preoperative BMIs and higher obstructive sleep-apnea syndrome rates. 
These data show that our population has characteristics close to those usually described for 
bariatric-surgery candidates. 
 Our study is the first to show with the QOLOD a significant increase after LSG in the 
physical, psycho-social, and sexual dimensions of QOL. Studies focusing on obesity-specific 
QOL following LSG are scarce, based on small samples and mainly measure QOL using the 
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Moorehead–Ardelt Quality of Life questionnaire [17-19], which is part of the Bariatric 
Analysis and Reporting Outcome System (BAROS). In line with these previous studies, our 
results support the hypothesis of a positive effect of LSG for improving physical, psycho-
social, and sexual QOL. Conversely, the positive effects of LAGB on physical, psycho-social, 
or sexual QOL have already been widely demonstrated [11-17].  
Thus, LSG seems to be at least as effective as LAGB in improving QOL. As LSG was 
also shown to be at least as effective as LAGB at improving weight loss and comorbidities 
[17, 28], our study adds further evidence to the benefit of LSG in obesity management. 
 Our study shows a significant improvement in ‘diet experience’ following both LAGB 
and LSG, and a significant increase in the short term ‘comfort with food’ dimension following 
LSG. This finding for LAGB seems surprising as digestive symptoms, such as heartburn and 
acid regurgitation, are commonly reported after LAGB [21, 29]. However, the QOLOD does 
not evaluate gastrointestinal symptoms themselves but rather their consequences on QOL. 
Indeed, QOL, defined as an individual's perception of their position in life, which 
encompasses physical, psychological, social, and spiritual dimensions, is a distinct concept 
from symptoms [30]. As QOL is an individual's perception, it can be hypothesized that, 
although gastrointestinal symptoms are frequent following LAGB, their consequences on 
eating and QOL are weak, and that the increase in QOL may be due to other variables that 
could be related to satisfaction from weight loss. This hypothesis is in line with Schweiger et 
al.’s findings, which show that, despite low food tolerance, LAGB patients had the same level 
of satisfaction as any other bariatric patients [20]. 
 Improvement in ‘comfort with food’ and ‘diet experience’ following LSG was 
observed in the present study. The positive effects of LSG on ‘quality of eating’ and ‘food 
tolerance’ have been rarely studied. Only Schweiger et al. reported results similar to ours [20]. 
We additionally found that LSG patients showed significantly better ‘comfort with food’ than 
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LAGB patients at 6 months, but not at the 12-month visit. Studying ‘quality of eating’ and 
‘comfort with food’ following bariatric surgery is a challenging area, as a decrease in ‘quality 
of eating’ may sometimes cause a gradual transition to eating soft and semi-liquid high-
calorie foods, which would favour weight regain. Contrary to the notion that all restrictive 
procedures have poor digestive and food tolerance outcomes [31], our results suggest that the 
type of restrictive surgery could directly impact on ‘comfort with food’ and QOL evolution, 
with a better profile for LSG. Our results also show that although the LSG group had better 
comfort with food compared to the LAGB group at the 6-month visit, the difference was not 
significant any more at the 12-month visit. Although these results could be partly explained 
by loss of statistical power due to loss of follow-up, the data suggest that beneficial effects in 
comfort with food of LSG over LAGB tend to plateau within the first post-operative year. 
 Although validity and reliability of the QOLOD rating scale is documented in obese 
patients with a mean BMI of 35 kg/m
2 
[23], it was not specifically validated in bariatric-
surgery candidates and was not designed to investigate QOL following bariatric surgery. 
However, the evaluation of physical, psycho-social, and sexual QOL with the QOLOD is 
comparable to that of the Moorehead–Ardelt Quality of Life Questionnaire [32], a 
questionnaire issued from the BAROS, and the most widely used QOL questionnaire in the 
field of bariatric surgery [33]. For instance, psycho-social QOL was assessed in both 
questionnaires using questions regarding level of sadness, and sexual QOL was assessed using 
questions that focused on the level of pleasure related to sexual relations. Our statistical 
analyses used linear mixed models considering only two covariates (gender and BMI). 
Because of overfitting problems due to the limited size of our study [34] we did not take into 
account any other covariates (e.g. history of a previous bariatric surgery, preoperative obesity 
comorbidities). Despite loss of follow-up and the limitation of the 12-month postoperative 
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period, our study provides significant results on the evolution of QOL in both LAGB and 
LSG using a reliable obesity-specific QOL questionnaire.  
In conclusion, our results show that both LSG and LAGB provide improvement in the 
physical, psycho-social, sexual, and diet experience domains of QOL. We also show that, 
within the first year of postoperative follow-up, there is no lasting difference in the comfort 
with food domain between the two procedures. Beyond weight loss, QOL should also be 
considered as a major outcome measure after bariatric surgery. Studies of the long-term 
differential effects of the various bariatric surgery procedures on QOL are warranted. 
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FIGURE LEGENDS 
Figure 1. Study flow chart 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Initial population 
175 patients with either LAGB or LSG 
Patients followed up at 12 months 
131 patients 
LAGB 
102 patients 
LSG 
29 patients 
Follow-up at 6 months 
- Physical impact: 91 patients 
- Psychosocial impact: 91 patients 
- Sexual impact: 90 patients 
- Comfort with food: 90 patients 
- Diet experience: 91 patients 
Follow-up at 12 months 
- Physical impact: 95 patients 
- Psychosocial impact: 95 patients 
- Sexual impact: 94 patients 
- Comfort with food: 95 patients 
- Diet experience: 95 patients 
Complete follow-up 
- Physical impact: 80 patients 
- Psychosocial impact: 80 patients 
- Sexual impact: 79 patients 
- Comfort with food: 79 patients 
- Diet experience: 80 patients 
 
Baseline 
- Physical impact: 28 patients 
- Psychosocial impact: 28 patients 
- Sexual impact: 28 patients 
- Comfort with food: 28 patients 
- Diet experience: 28 patients 
Follow-up at 6 months 
- Physical impact: 25 patients 
- Psychosocial impact: 25 patients 
- Sexual impact: 25 patients 
- Comfort with food: 25 patients 
- Diet experience: 25 patients 
Follow-up at 12 months 
- Physical impact: 28 patients 
- Psychosocial impact: 28 patients 
- Sexual impact: 28 patients 
- Comfort with food: 28 patients 
- Diet experience: 28 patients 
Complete follow-up 
- Physical impact: 24 patients 
- Psychosocial impact: 24 patients 
- Sexual impact: 24 patients 
- Comfort with food: 24 patients 
- Diet experience: 24 patients 
Baseline 
- Physical impact: 94 patients 
- Psychosocial impact: 94 patients 
- Sexual impact: 94 patients 
- Comfort with food: 93 patients 
- Diet experience: 94 patients 
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Table 1. Characteristics of study population 
 
Adjustable gastric 
banding 
(n=102) 
Sleeve 
gastrectomy 
(n=29) 
p-value 
  
Age at baseline (years) 39.3 ± 9.6 41.0 ± 10.6 0.45 
Gender   0.36 
Male 17 (16.7%) 7 (24.1%)  
Female 85 (83.3%) 22 (75.9%)  
Socio-professional category   0.52 
   Farmers 3 (2.9%) 0  
   Tradesmen, shopkeepers and business 
owners 5 (4.9%) 2 (6.9%)  
   Managers and secondary/University 
teachers 2 (2.0%) 2 (6.9%)  
   Intermediate professions 9 (8.8%) 2 (6.9%)  
   White-collar workers 48 (47.1%) 11 (37.9%)  
   Blue-collar workers 9 (8.8%) 1 (3.5%)  
   Unemployed 26 (25.5%) 11 (37.9%)  
Marital status   0.24 
   Single 13 (12.8%) 5 (17.2%)  
   Divorced 14 (13.7%) 1 (3.5%)  
   Married or in a relationship 74 (72.5%) 22 (75.8%)  
   Widowed 1 (1.0%) 1 (3.5%)  
Previous maximal BMI (kg/m
2
) 49.6 ± 5.8 56.4 ± 10.6 0.0006 
Preoperative BMI (kg/m
2
) 48.1 ± 6.1 54.3 ± 10.1 0.0016 
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Preoperative obesity comorbidities     
   Hypertension 39 (38.2%) 10 (34.5%) 0.71 
   Diabetes 17 (16.7%) 6 (20.7%) 0.62 
   Dyslipidaemia 39 (38.2%) 17 (58.6%) 0.05 
   Obstructive sleep-apnea syndrome 30 (29.4%) 13 (44.8%) 0.19 
   Coronary arterial disease 2 (2.0%) 1 (3.5%) 0.53 
   Sterility 3 (2.9%) 1 (3.5%) 1.00 
   Active smoking 25 (24.5%) 6 (20.7%) 0.67 
History of previous bariatric surgery 4 (3.9%) 6 (20.7%) 0.008 
Data are means ± standard deviations. We compared both groups’ characteristics using 
Wilcoxon and chi-squared tests. We used Fisher’s exact test when expected frequencies were 
too small.  
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Table 2. Evolution over the one year of follow-up 
 
Adjustable gastric banding  Sleeve gastrectomy 
Baseline 6 months 12 months   Baseline 6 months 12 months 
Weight (kg) 129.8 ± 21.0 111.6 ± 18.7 107.9 ± 18.9  149.7 ± 38,1 122.7 ± 33.7 117.2 ± 33.7 
BMI (kg/m
2
) 48.1 ± 6.1 41.6 ± 5.9 40.2 ± 6.1  54.3 ± 10.1 44.3 ± 9.0 42.2 ± 9.4 
Excess weight loss (%)   28.4 ± 14.7 34.8 ± 18.4   35.7 ± 14.3 43.8 ± 17.8 
Waist circumference (cm) 123.1 ± 13.6 111.9 ± 12.9 109.3 ± 13.3  141.9 ± 23.2 124.5 ± 21.7 121.8 ± 22.2 
Hip circumference (cm) 143.7 ± 12.1 131.8 ± 12.2 129.4 ± 12.5  155.8 ± 20.5 137.9 ± 20.3 135.3 ± 21.1 
Surgical reoperation (cumulative incidence)  9 (8.8%) 20 (19.6%)   5 (17.2%) 5 (17.2%) 
Postoperative gastric fistula (cumulative incidence)  0 0   3 (10.3%) 3 (10.3%) 
Medications        
   Antidepressants 7 (6.9%) 5 (5.1%) 4 (4.0%)  5 (17.2%) 3 (10.7%) 4 (14.8%) 
   Anxiolytic or hypnotic 10 (9.9%) 9 (9.2%) 9 (8.9%)  3 (10.3%) 1 (3.6%) 2 (7.4%) 
Quality of life scores        
   Physical impact 31.3 ± 8.2 41.9 ± 7.1 43.1 ± 6.9  31.1 ± 7.8 42.7 ± 6.1 42.4 ± 7.1 
   Psycho-social impact 32.6 ± 8.3 39.9 ± 8.5 40.5 ± 8.3  36.7 ± 8.5 44.0 ± 8.5 42.7 ± 9.6 
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   Sexual impact 13.4 ± 4.4 15.7 ± 4.1 15.9 ± 3.9  14.9 ± 4.6 17.0 ± 3.1 16.4 ± 3.5 
   Comfort with food 13.4 ± 4.2 14.4 ± 3.9 14.2 ± 4.3  14.2 ± 4.0 17.2 ± 3.9 15.4 ± 4.2 
   Diet experience 14.3 ± 4.3 16.9 ± 4.0 16.8 ± 3.9  16.0 ± 4.8 18.3 ± 5.4 16.9 ± 5.7 
Data are means ± standard deviations. Per cent excess weight loss is calculated as follows: Weight loss x 100 / (preoperative weight – weight if 
BMI was 25 kg/m
2
) 
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Table 3. Fixed effects of the independent variables on quality of life 
Effect  Physical impact  Psycho-social impact  Sexual impact  Comfort with food  Diet experience 
 Estimation p-value  Estimation p-value  Estimation p-value  Estimation p-value  Estimation p-value 
Intercept 51.12 ± 3.42 <0.0001  45.68 ± 3.80 <0.0001  17.09 ± 1.85 <0.0001  13.39 ± 2.01 <0.0001  15.31 ± 2.10 <0.0001 
Time  <0.0001   <0.0001   0.0009   <0.0001   <0.0001 
      T0 - -  - -  - -  - -  - - 
      T6 7.72 ± 0.74 <0.0001  5.01 ± 0.79 <0.0001  1.50 ± 0.40 0.0002  1.12 ± 0.47 0.018  2.30 ± 0.47 <0.0001 
      T12 7.97 ± 0.87 <0.0001  4.92 ± 1.01 <0.0001  1.58 ± 0.48 0.001  0.76 ± 0.57 0.18  2.03 ± 0.56 <0.0001 
Type of surgery               
      Gastric banding - -  - -  - -  - -  - - 
      Sleeve 1.36 ± 1.35 0.32  4.27 ± 1.49 0.0048  1.13 ± 0.72 0.12  0.87 ± 0.93 0.35  1.20 ± 0.80 0.14 
Gender               
      Female - -  - -  - -  - -  - - 
      Male 1.90 ± 1.43 0.19  6.97 ± 1.57 <0.0001  3.33 ± 0.77 <0.0001  -0.40 ± 0.80 0.62  1.36 ± 0.85 0.11 
BMI -0.41 ± 0.07 <0.0001  -0.29 ± 0.08 0.0002  -0.08 ± 0.04 0.024  -0.002 ± 0.04 0.97  -0.02 ± 0.04 0.58 
 Surgery type*time           0.029    
      Sleeve group*T6          1.95 ± 0.82 0.018    
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      Sleeve group*T12          0.46 ± 1.00 0.65    
Results are based on linear mixed models adjusted for gender and BMI at each visit. Data are parameter estimation ± standard errors. T0, T6, and 
T12 are assessments at the preoperative and at 6- and 12-month postoperative visits, respectively. * Mean interactions between two variables. 
